Literature DB >> 11743571

Danazol and limb-threatening arterial thrombosis: two case reports.

R G Alvarado1, J Y Liu, R M Zwolak.   

Abstract

Danazol is a synthetic androgenic steroid used clinically for the treatment of a wide variety of disorders. Although there is no extensive evidence that androgens are thrombogenic in humans, there are case reports of cerebral, coronary, and peripheral arterial thrombosis in young male athletes abusing anabolic-androgenic steroids. There are also two reported cases of arterial and venous thrombotic events attributed to danazol therapy. We report two additional cases of limb-threatening arterial thrombosis in patients undergoing danazol therapy, and suggest the possibility that danazol may be an independent risk factor for arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743571     DOI: 10.1067/mva.2001.118078

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

Review 1.  Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.

Authors:  Magdalena Bofill Rodriguez; Sofia Dias; Vanessa Jordan; Anne Lethaby; Sarah F Lensen; Michelle R Wise; Jack Wilkinson; Julie Brown; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-05-31

2.  Successful treatment in one myelodysplastic syndrome patient with primary thrombocytopenia and secondary deep vein thrombosis: A case report.

Authors:  Wen-Bin Liu; Jian-Xiong Ma; Hong-Xuan Tong
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

3.  Pulmonary Thromboembolism in Immune Thrombocytopenia: A Report of Five Cases and a Review of the Literature.

Authors:  Yong Tan; Min Yan; Zhen Cheng; Xiangtao Pan
Journal:  Int J Gen Med       Date:  2021-08-13

4.  Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura.

Authors:  Hak Young Rhee; Hye-Yeon Choi; Sang-Beom Kim; Won-Chul Shin
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 5.  A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.

Authors:  Ian S Fraser; Robert J Porte; Peter A Kouides; Andrea S Lukes
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 6.  Endometriosis still a challenge.

Authors:  C Mehedintu; M N Plotogea; S Ionescu; M Antonovici
Journal:  J Med Life       Date:  2014-09-25

7.  Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.

Authors:  Gulsen Akoglu; Belgin Kesim; Gokhan Yildiz; Ahmet Metin
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.